|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 48/00 | |
| C12N 15/861 |
| (11) | Patento numeris | 1436313 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 02801473.6 |
| Europos patento paraiškos padavimo data | 2002-05-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-07-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-09-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2002/000339 |
| Data | 2002-05-01 |
| (87) | Numeris | WO 2003/033514 |
| Data | 2003-04-24 |
| (30) | Numeris | Data | Šalis |
| 330118 P | 2001-10-19 | US |
| (72) |
HARATS, Dror, IL
GREENBERGER, Shoshana, IL
BREITBART, Eyal, IL
|
| (73) |
Vascular Biogenics Ltd.,
6 Jonathan Netanyahu Street, 60376 Or Yehuda,
IL
|
| (54) | POLYNUCLEOTIDE CONSTRUCTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TARGETED DOWNREGULATION OF ANGIOGENESIS AND ANTICANCER THERAPY |
| POLYNUCLEOTIDE CONSTRUCTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TARGETED DOWNREGULATION OF ANGIOGENESIS AND ANTICANCER THERAPY |